| Followers | 65 |
| Posts | 10174 |
| Boards Moderated | 0 |
| Alias Born | 03/29/2015 |
Sunday, August 27, 2023 6:42:16 PM
The cause is not dishonesty but that NWBO wasted a huge chance to restore damaged trust with opposition shareholders in September 2020 when they said to us that our long wait for TLD was coming to an end - that same month.
Then the month came to an end and we waited 5 days only to learn they they were not merely running a little late as we hoped and prayed but that no, they had decided ‘No we’re going to drag you through hell some more.’
Once more those of us who trusted management again our better judgment we’re made fools before family and friends.
They shattered trust that was just beginning to be restored and nothing they’ve done since has helped repair the damage.
So by the time they talk about spoofing, we just aren’t going to credit it.
It comes across as another in a long series of shiny things to act as a pressure release valve so that the payoff for shareholders can be delayed for reasons that make no sense.
If they had made a different decision almost three years ago, then they would have had fewer shareholders opposing them.
Then the month came to an end and we waited 5 days only to learn they they were not merely running a little late as we hoped and prayed but that no, they had decided ‘No we’re going to drag you through hell some more.’
Once more those of us who trusted management again our better judgment we’re made fools before family and friends.
They shattered trust that was just beginning to be restored and nothing they’ve done since has helped repair the damage.
So by the time they talk about spoofing, we just aren’t going to credit it.
It comes across as another in a long series of shiny things to act as a pressure release valve so that the payoff for shareholders can be delayed for reasons that make no sense.
If they had made a different decision almost three years ago, then they would have had fewer shareholders opposing them.
Recent NWBO News
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:38:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
